Primäre und sekundäre Demenzen

  • N. T. Lautenschlager
  • H. Förstl
Conference paper


Die Konnotation der Beziechnung „primäre“ Demenz umfasst die Eigenschaften „häufig, gesetzäßig, unweigerlich, genuin, kryptogen,...“.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alexander EL (1993) Neurologic disease in Sjogren’s syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscles, a clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 19: 869–908PubMedGoogle Scholar
  2. 2.
    American Academy of Neurology AIDS Task Force (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41: 778–785CrossRefGoogle Scholar
  3. 3.
    Bell IR, Edman JS, Marby DW et al. (1990) Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biol Psychiatry 27: 125–137PubMedCrossRefGoogle Scholar
  4. 4.
    Bell IR, Edman JS, Miller Jet al. (1990) Relationship of normal serum vitamin B12 to cognitive test performance in subtypes of geriatric major depression. J Geriatr Psychiatry Neurol 3: 98–105PubMedCrossRefGoogle Scholar
  5. 5.
    Brashear A, Unverzagt FW, Farber MO et al. (1996) Ethylene oxide neurotoxicity: a cluster of 12 nurses with peripheral and central nervous system toxicity. Neurology 46: 992–998PubMedCrossRefGoogle Scholar
  6. 6.
    Brewer CJ, Fink JK, Hedera P (1999) Diagnosis and Treatment of Wilson’s Disease. Seminars in Neurology 19: 261–270PubMedCrossRefGoogle Scholar
  7. 7.
    Carmel R (1997) Cobalamin, the stomach, and ageing. Am J Clin Nutr 66: 750–759PubMedGoogle Scholar
  8. 8.
    Clifford DB (2002) AIDS dementia. Med Clin North Am 86: 537–550PubMedCrossRefGoogle Scholar
  9. 9.
    Crystal HA, Dickson D, Davis P, Masur D, Grober E, Lipton RB (2001) The relative frequency of “dementia of unknown etiology” increases with age and is nearly 50% in nonagenarians. Arch Neurol 58: 1498–1499CrossRefGoogle Scholar
  10. 10.
    Cummings JL, Benson DF (1992) Dementia: A clinical approach., 2ndedn. Butterworth, Stoneham, MAGoogle Scholar
  11. 11.
    Denburg SD, Denburg JA, Carbotte RM et al. (1993) Cognitive deficits in systemic lupus erythematosus. Theum Dis Clin North Am 19: 815–831Google Scholar
  12. 12.
    Devinsky 0 (1995) Cognitive and behavioural effects of antiepileptic drugs. Epilepsia 36 (Suppl 2): S46–65CrossRefGoogle Scholar
  13. 13.
    Ellis WG, Sobel RA, Nielsen SL (1982) Leukoencephalopathy in patients treated with amphotericin B methyl ester. J Infect Dis 146: 125–137PubMedCrossRefGoogle Scholar
  14. 14.
    Fallon BA, Nields JA (1994) Lyme disease: a neuropsychiatric illness. Am J Psychiatry 151: 1571–1583PubMedGoogle Scholar
  15. 15.
    Filley CM, Heaton RK, Rosenberg NL (1990) White matter dementia in chronic toluene abuse. Neurology 40: 532–534PubMedCrossRefGoogle Scholar
  16. 16.
    Finlay BL, Darlington RB (1995) Linked regularities in the development and evolution of mammalian brains. Science 268: 1578–1584PubMedCrossRefGoogle Scholar
  17. 17.
    Fioravanti M, Ferrario E, Massaia M (1997) Low folate levels in the cognitive decline of eldelry patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr 26: 1–13CrossRefGoogle Scholar
  18. 18.
    Hankey GJ (2002) Is homocysteine a causal and treatable risk factor for vascular disease of the brain (cognitive impairment and stroke)? Ann Neurol 51: 279–281PubMedCrossRefGoogle Scholar
  19. 19.
    Hanley JG (1998) Evaluation of patients with CNS involvement in SLE. Baillieres Clin Rheum 12: 415–431CrossRefGoogle Scholar
  20. 20.
    Hwang TL, Yung WK, Estey EH et al. (1985) Central nervous system toxicity with high-dose Ara-C. Neurology 35: 1475–1479PubMedCrossRefGoogle Scholar
  21. 21.
    Janssen RS, Nwanyanwu OC, Selik RM et al. (1992) Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42: 1472–1476PubMedCrossRefGoogle Scholar
  22. 22.
    Martin DC, Francis J, Protech J, Huff JF (1992) Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 40: 168–172PubMedGoogle Scholar
  23. 23.
    Morley JE (1997) Anorexia of ageing: physiologic and pathologic. Am J Clin Nutr 66: 760–773PubMedGoogle Scholar
  24. 24.
    Moutsopoulos HM, Sarmas JH, Talal N (1993) Is central nervous system involvement a systemic manifestation of primary Sjogren’s syndrome? Rheum Dis Clin North Am 19: 909–912PubMedGoogle Scholar
  25. 25.
    MRC CFAS Study (2001) Pathological correlates of late-onset dementia in multicentre, community-based population in England and Wales. Lancet 357: 169–175Google Scholar
  26. 26.
    Papazian 0, Canziales E, Alfonso I et al. (1995) Reversible dementia and apparent brain atrophy during valproate therapy. Ann Neurol 38: 687–691PubMedCrossRefGoogle Scholar
  27. 27.
    Parsons OA (1998) Neurocognitive deficits in alcoholics and social drinkers: a continuum? Alcohol Clin Exp Res 22: 954–961PubMedGoogle Scholar
  28. 28.
    Pavol MA, MeyersCA, Rexer JL et al. (1995) Pettern of neurobehavioral deficits associated with interferon alfa. Neurology 45: 947–950PubMedCrossRefGoogle Scholar
  29. 29.
    Peyser JM, Rao SM, LaRocca NG, Kaplan E (1990) Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol 47: 94–97PubMedCrossRefGoogle Scholar
  30. 30.
    Power C, Johnson RT (1995) HIV-1 associated dementia: clinical features and pathogenesis. Can J Neurol Sci 22: 92–100PubMedGoogle Scholar
  31. 31.
    Rao SM (1996) White matter disease and dementia. Brain Cogn 31: 250–268PubMedCrossRefGoogle Scholar
  32. 32.
    Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. 1. Frequency patterns and prediction. Neurology 41: 685–691PubMedCrossRefGoogle Scholar
  33. 33.
    Rourke SB, Grant I (1999) The interactive effects of age and length of abstinence on the recovery of neuropsychological functioning in chronic male alcoholics: a 2-year follow-up study. J Int Neuropsychol Soc 5: 234–246PubMedCrossRefGoogle Scholar
  34. 34.
    Spencer MD, Knight RS, Will RG (2002) First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case review of early psychiatric and neurological features. BMJ 324: 1479–1482PubMedCrossRefGoogle Scholar
  35. 35.
    Swirsky-Sachetti T, Mitchell DR, Seward Jet al. (1992) Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology 42: 1291–1295CrossRefGoogle Scholar
  36. 36.
    Victor M (1994) Alcoholic Dementia. Can J Neurol Sci: 88–99Google Scholar
  37. 37.
    Waniek C, Prohovnik I, Kaufman MA et al. (1995) Rapidly progressive frontal-type dementia associated with Lyme disease. J Neuropsychiatry Clin Neurosci 7: 345–347PubMedGoogle Scholar
  38. 38.
    West SG (1994) Neuropsychiatric lupus. Rheum Dis Clin North Am 20: 367–370Google Scholar
  39. 39.
    Yamamori C, Oshino H, Inagaki T et al. (1994) Neuro-Behget disease with demyelination and gliosis of the frontal white matter. Clinc Neuropathol 13: 208–215Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • N. T. Lautenschlager
  • H. Förstl

There are no affiliations available

Personalised recommendations